share_log

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Maynard Ryan D

SEC ·  Nov 14, 2024 14:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more